Nuwellis (NUWE) EBT Margin (QoQ) (2014 - 2026)
Nuwellis (NUWE) EBT Margin (QoQ) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn |
| 10 | Nuwellis | 212,054.30 | -3.71 Mn | 1.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -5,623.00 |
| Mar 31, 2026 | -8,905.00 |
| Dec 31, 2025 | -12,103.00 |
| Sep 30, 2025 | 74,859.00 |
| Jun 30, 2025 | -56,923.00 |
| Mar 31, 2025 | -9,507.00 |
| Dec 31, 2024 | -16,280.00 |
| Sep 30, 2024 | 45,163.00 |
| Jun 30, 2024 | -11,894.00 |
| Mar 31, 2024 | -1,593.00 |
| Dec 31, 2023 | -7,750.00 |
| Sep 30, 2023 | 9,376.00 |
| Jun 30, 2023 | 12,164.00 |
| Mar 31, 2023 | -27,261.00 |
| Dec 31, 2022 | 10,488.00 |
| Sep 30, 2022 | 627.00 |
| Jun 30, 2022 | 3,856.00 |
| Mar 31, 2022 | -116,113.00 |
| Dec 31, 2021 | 121,339.00 |
| Sep 30, 2021 | -9,589.00 |